Evidence map›Paper›PMID 36269183›Full record

ArticleTranslational vision science & technology2022

Feasibility of Magnetic Levator Prosthesis Frame Customization Using Craniofacial Scans and 3-D Printing.

Kevin E Houston, Eleftherios I Paschalis

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04678115 (A Randomized Cross-Over Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04678115 nacompletednot on this map

A Randomized Cross-Over Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis

TypeinterventionalSponsorMassachusetts Eye and Ear InfirmaryRan2021 to 2024Enrolled16ConditionsBlepharoptosis, Ptosis, Eyelid, Myasthenia Gravis, StrokeArmsMagnetic Levator Prosthesis (MLP), Kinesiotape Frontalis Sling (KTFS)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kevin E HoustonMassachusetts Eye and Ear, Boston, MA, USA.
Eleftherios I PaschalisMassachusetts Eye and Ear, Boston, MA, USA.
Harvard University · USSmith-Kettlewell Eye Research Institute · US

Funding

Management of Blepharoptosis with Neodymium Magnet Systems: The Boston Blink-netic ProjectR01EY029437 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI HOUSTON, KEVIN EDWARD · 2018 to 2022
$2.5M
A Custom-Print Adjustable Force Magnetic Device for Severe BlepharoptosisR43EY029901 · NEI · SKELMET, INC. · PI CAO, YU · 2019 to 2019
$149k
NEI NIH HHS R01 EY029437NEI NIH HHS R43 EY029901
6 · The paper itself

Abstract

Purpose: To determine the feasibility of a custom frame generation approach for nonsurgical management of severe blepharoptosis with the magnetic levator prosthesis (MLP). Methods: Participants (n = 8) with severe blepharoptosis (obscuring the visual axis) in one or both eyes who had previously been using a non-custom MLP had a craniofacial scan with a smartphone app to generate a custom MLP frame. A magnetic adhesive was attached to the affected eyelid. The custom MLP frame held a cylindrical magnet near the eyebrow above the affected eyelid, suspending it in the magnetic field while still allowing blinking. The spectacle magnet could be rotated manually, providing adjustable force via angular translation of the magnetic field. Fitting success and comfort were recorded, and interpalpebral fissure (IPF) was measured from video frames after 20 minutes in-office and one-week at-home use. Preference was documented, custom versus non-custom. Results: Overall, 88% of patients (7/8) were successfully fitted with a median 9/10 comfort (interquartile 7-10) and median ptosis improvement of 2.3 mm (1.3-5.0); P = 0.01). Exact binomial testing suggested, with 80% power, that the true population success rate was significantly greater than 45% (P = 0.05). Five participants took the custom MLP home for one week, with only one case of mild conjunctival redness which resolved without treatment. Highest to lowest force modulation resulted in a marginally significant median IPF adjustment of 1.5 mm (0.8 to 2.7; P = 0.06). All preferred the custom frame. Conclusions: The three-dimensional custom MLP frame generation approach using a smartphone app-based craniofacial scan is a feasible approach for clinical deployment of the MLP. Translational Relevance: First demonstration of customized frame generation for the MLP.

Indexed as

Artificial LimbsBlepharoptosisFeasibility StudiesHumansMagnetic PhenomenaOculomotor MusclesPrinting, Three-Dimensional

Identifiers

PMID36269183
PMCPMC9617505
OpenAlexW4307033257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.